Search research articles
Contact Us
Filters
Showing results (621-630 of 641) with videos related to
Page
of 65
Sort By:
Blood Advances
|
October 25, 2023
CD8 effector T cells enhance teclistamab response in BCMA-exposed and -naïve multiple myeloma
Ross S Firestone, Devin McAvoy, Tala Shekarkhand, et al.
JAMA Surgery
|
May 7, 2025
Breast Tumor-Bed Biopsy for Pathological Complete Response Prediction: The NRG-BR005 Nonrandomized Clinical Trial
Mark Basik, Reena S Cecchini, Jennifer F De Los Santos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 4, 2024
Phase I Trial of MCARH109, a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma: An Updated Analysis
Eric M Jurgens, Ross S Firestone, Jagrutiben Chaudhari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 25, 2025
Immune-MRD status informs tumor-MRD outcome prognostication in patients with multiple myeloma on lenalidomide maintenance
Ross S Firestone, Anish K Simhal, Devin McAvoy, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 24, 2025
Robust CD4<sup>+</sup> CAR T cell Expansion Is Associated with Non-ICANS Neurotoxicities Following Ciltacabtagene Autoleucel
Eric M Jurgens, Sneha Mitra, Kevin Herrera, et al.
Journal of Hepatology
|
August 14, 2025
Phase I trial of ADP-A2AFP TCR T-cell therapy in patients with advanced hepatocellular or gastric hepatoid carcinoma
Tim Meyer, Richard S Finn, Mitesh Borad, et al.
JAMA Oncology
|
September 6, 2019
Assessment of Treatment With Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients With Advanced Hepatocellular Carcinoma: Phase 3 CALGB 80802 Randomized Clinical Trial
Ghassan K Abou-Alfa, Qian Shi, Jennifer J Knox, et al.
Cancer Chemotherapy and Pharmacology
|
August 10, 2010
A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies
Paula M Fracasso, Kerry J Williams, Ronald C Chen, et al.
The Lancet Regional Health. Southeast Asia
|
April 23, 2026
Burden and risk factors of influenza-associated acute respiratory infections among older adults in India: a multicentric community-based surveillance (2018-2023)
Prabu Rajkumar, Girish Kumar Chethrapilly Purushothaman, Ritvik Amarchand, et al.
The Oncologist
|
August 28, 2016
Clinical Actionability of Comprehensive Genomic Profiling for Management of Rare or Refractory Cancers
Kim M Hirshfield, Denis Tolkunov, Hua Zhong, et al.
Page
of 65
Search research articles
Search
Showing results (621-630 of 641) with videos related to
Sort By:
Page
of 65
Blood Advances
|
October 25, 2023
CD8 effector T cells enhance teclistamab response in BCMA-exposed and -naïve multiple myeloma
Ross S Firestone, Devin McAvoy, Tala Shekarkhand, et al.
JAMA Surgery
|
May 7, 2025
Breast Tumor-Bed Biopsy for Pathological Complete Response Prediction: The NRG-BR005 Nonrandomized Clinical Trial
Mark Basik, Reena S Cecchini, Jennifer F De Los Santos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 4, 2024
Phase I Trial of MCARH109, a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma: An Updated Analysis
Eric M Jurgens, Ross S Firestone, Jagrutiben Chaudhari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 25, 2025
Immune-MRD status informs tumor-MRD outcome prognostication in patients with multiple myeloma on lenalidomide maintenance
Ross S Firestone, Anish K Simhal, Devin McAvoy, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 24, 2025
Robust CD4<sup>+</sup> CAR T cell Expansion Is Associated with Non-ICANS Neurotoxicities Following Ciltacabtagene Autoleucel
Eric M Jurgens, Sneha Mitra, Kevin Herrera, et al.
Journal of Hepatology
|
August 14, 2025
Phase I trial of ADP-A2AFP TCR T-cell therapy in patients with advanced hepatocellular or gastric hepatoid carcinoma
Tim Meyer, Richard S Finn, Mitesh Borad, et al.
JAMA Oncology
|
September 6, 2019
Assessment of Treatment With Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients With Advanced Hepatocellular Carcinoma: Phase 3 CALGB 80802 Randomized Clinical Trial
Ghassan K Abou-Alfa, Qian Shi, Jennifer J Knox, et al.
Cancer Chemotherapy and Pharmacology
|
August 10, 2010
A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies
Paula M Fracasso, Kerry J Williams, Ronald C Chen, et al.
The Lancet Regional Health. Southeast Asia
|
April 23, 2026
Burden and risk factors of influenza-associated acute respiratory infections among older adults in India: a multicentric community-based surveillance (2018-2023)
Prabu Rajkumar, Girish Kumar Chethrapilly Purushothaman, Ritvik Amarchand, et al.
The Oncologist
|
August 28, 2016
Clinical Actionability of Comprehensive Genomic Profiling for Management of Rare or Refractory Cancers
Kim M Hirshfield, Denis Tolkunov, Hua Zhong, et al.
Page
of 65